UroGen Pharma Ltd. (URGN)

41.35 +0.12 (+0.29%) USD  |  NASDAQ  |  Sep 25, 16:00
41.34 -0.01 (-0.02%) After-Hours: 19:59
More

UroGen Pharma Cash and Short Term Investments (Annual) : 121.81M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for URGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2015. Start Trial.
Date Value
December 31, 2025 121.81M
December 31, 2024 237.76M
December 31, 2023 137.79M
December 31, 2022 100.78M
December 31, 2021 90.36M
December 31, 2020 103.24M
Date Value
December 31, 2019 147.60M
December 31, 2018 101.57M
December 31, 2017 73.20M
December 31, 2016 21.46M
December 31, 2015 18.00M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Xencor, Inc. 547.73M
MeiraGTx Holdings Plc 65.93M
Insmed, Inc. 1.430B
Ironwood Pharmaceuticals, Inc. 215.46M
Viking Therapeutics, Inc. 705.74M